Furthermore, our group identified MAP peptides homologous to proinsulin (PI) that were highly recognized in new-onset T1D children from continental Italy (45,7–49,1%) compared to healthy controls (3,3%), hypothesizing a cross-reaction between Abs targeting the homologous PI/MAP region [18]. The gene discussed is INS; the disease is type 1 diabetes mellitus.